ES544926A0 - Procedimiento de obtencion de 2-amino oxazolinas - Google Patents

Procedimiento de obtencion de 2-amino oxazolinas

Info

Publication number
ES544926A0
ES544926A0 ES544926A ES544926A ES544926A0 ES 544926 A0 ES544926 A0 ES 544926A0 ES 544926 A ES544926 A ES 544926A ES 544926 A ES544926 A ES 544926A ES 544926 A0 ES544926 A0 ES 544926A0
Authority
ES
Spain
Prior art keywords
radical
lower alkyl
hydrogen
equal
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544926A
Other languages
English (en)
Other versions
ES8700853A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Albert Rolland SA
Original Assignee
Laboratoires Albert Rolland SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Albert Rolland SA filed Critical Laboratoires Albert Rolland SA
Publication of ES544926A0 publication Critical patent/ES544926A0/es
Publication of ES8700853A1 publication Critical patent/ES8700853A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES544926A 1984-07-05 1985-07-05 Procedimiento de obtencion de 2-amino oxazolinas Expired ES8700853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH326384 1984-07-05

Publications (2)

Publication Number Publication Date
ES544926A0 true ES544926A0 (es) 1986-10-16
ES8700853A1 ES8700853A1 (es) 1986-10-16

Family

ID=4252197

Family Applications (2)

Application Number Title Priority Date Filing Date
ES544926A Expired ES8700853A1 (es) 1984-07-05 1985-07-05 Procedimiento de obtencion de 2-amino oxazolinas
ES553058A Expired ES8705364A1 (es) 1984-07-05 1986-03-15 Procedimiento de preparacion de aminoacidos opticamente activos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES553058A Expired ES8705364A1 (es) 1984-07-05 1986-03-15 Procedimiento de preparacion de aminoacidos opticamente activos.

Country Status (14)

Country Link
EP (1) EP0167459B1 (es)
JP (1) JPS61155375A (es)
AT (1) ATE69222T1 (es)
AU (1) AU579872B2 (es)
CA (1) CA1258040A (es)
DD (1) DD240015A5 (es)
DE (1) DE3584584D1 (es)
DK (1) DK302185A (es)
ES (2) ES8700853A1 (es)
HU (1) HU193333B (es)
MA (1) MA20480A1 (es)
OA (1) OA08166A (es)
PL (1) PL254398A1 (es)
PT (1) PT80779B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632860A1 (fr) * 1988-06-21 1989-12-22 Rolland Sa A Nouveaux medicaments antidepresseurs et les compositions pharmaceutiques en renfermant
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
DE69524962T4 (de) * 1994-08-22 2003-08-28 Mitsubishi Pharma Corp., Osaka Benzolderivate und deren medizinische verwendung
MXPA04006709A (es) 2002-01-11 2004-10-04 Sankyo Co Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물
CA2675221C (en) * 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
MX2009008465A (es) 2007-02-15 2009-08-20 Hoffmann La Roche Nuevas 2-aminooxazolinas como ligandos de taar1.
CN101952260B (zh) * 2008-02-18 2013-02-13 弗·哈夫曼-拉罗切有限公司 4,5-二氢-*唑-2-基胺衍生物
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
ES2556633T3 (es) * 2008-07-24 2016-01-19 F. Hoffmann-La Roche Ag Derivados de 4,5-dihidro-oxazol-2-ilo
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
US8673950B2 (en) 2010-11-02 2014-03-18 Hoffmann-Laroche Inc. Dihydrooxazol-2-amine derivatives
RS60825B1 (sr) 2016-03-17 2020-10-30 Hoffmann La Roche Aktivnost derivata 5-etiol-4-metil-pirazol-3-karboksamida kao agonista taar-a

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448M (fr) * 1963-02-27 1964-04-06 Mcneilab Inc Composé de la classe des 2-amino-5-aryl-oxazolines et compositions pharmaceutiques le contenant.
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
US4647557A (en) * 1982-12-28 1987-03-03 Gerard Moinet Novel heterocyclic derivatives bearing an amino radical, processes for their production and the pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS61155375A (ja) 1986-07-15
ATE69222T1 (de) 1991-11-15
PT80779B (fr) 1987-01-12
HUT38918A (en) 1986-07-28
AU579872B2 (en) 1988-12-15
AU4468185A (en) 1986-01-30
ES553058A0 (es) 1987-05-01
EP0167459A3 (en) 1987-02-25
PT80779A (fr) 1985-08-01
DD240015A5 (de) 1986-10-15
OA08166A (fr) 1987-03-31
DE3584584D1 (de) 1991-12-12
EP0167459A2 (fr) 1986-01-08
CA1258040A (fr) 1989-08-01
ES8700853A1 (es) 1986-10-16
PL254398A1 (en) 1986-06-17
HU193333B (en) 1987-09-28
EP0167459B1 (fr) 1991-11-06
MA20480A1 (fr) 1986-04-01
DK302185A (da) 1986-01-06
ES8705364A1 (es) 1987-05-01
DK302185D0 (da) 1985-07-03

Similar Documents

Publication Publication Date Title
AU579872B2 (en) 2-amino-4-substituted oxazolines
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
MX9202142A (es) Nuevos derivados de urea, proceso para su preparacion, y composicion farmaceutica que los comprende.
ATE116982T1 (de) 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine.
FI885594A0 (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
NO306510B1 (no) Androsteroner, anvendelse derav og farmasöytisk formulering
SE8802412D0 (sv) Thiourea derivatives
IE822310L (en) Triazoloquinazolone derivatives
NZ240978A (en) Benzoxazinone and benzothiazinone derivatives, preparation and pharmaceutical compositions thereof
PE20000645A1 (es) Derivados de 3-(2-oxo-[1,3`]bipirrolidinil-3-ilidenmetil)-cefemos
DE69925250D1 (de) Aktivatoren der kalium-kanäle
DE69427394D1 (de) Kondensierte heterocyclische glutaminsäurederivate als antiproliferative mittel
ATE78814T1 (de) Thioformamidderivate.
ES507269A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenzofurano.
ATE73801T1 (de) Heterocyclische oxophthalazinylessigsaeure.